Condition: Asthma
Interventions: Device: ELLIPTA DPI; Device: GSK MDI; Device: AZ MDI
Sponsor: GlaxoSmithKline
Not yet recruiting – verified June 2016
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
A Randomized Trial Comparing Metered Dose Inhalers and Breath Actuated Nebulizers
Condition: Asthma
Interventions: Device: Metered Dose Inhaler; Device: Breath Actuated Nebulizer
Sponsors: Le Bonheur Children’s Hospital; University of Tennessee Health Science Center
Completed – verified May 2016
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
Pharmacodynamic Bioequivalence of Metered Dose Inhalers of Albuterol Sulfate in Patients With Stable Mild Asthma
Condition: Mild Asthma
Interventions: Drug: 90 mcg Reference Product; Drug: 180 mcg Reference Product; Drug: 90 mcg Test Product; Drug: Placebo
Sponsor: Cipla Ltd.
Not yet recruiting – verified December 2015
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
Safety and Efficacy of Berodual® Inhaled Via Respimat® Compared to MDI (Metered Dose Inhaler) in Pediatric Patients With Asthma
Condition: Asthma
Interventions: Drug: Berodual® Respimat®, low dose; Drug: Berodual® Respimat®, high dose; Drug: Berodual® MDI
Sponsor: Boehringer Ingelheim
Completed – verified July 2014
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
Effect on Fenoterol Metered Dose Inhaler on the Beta-receptor Population on Lymphocytes in Patients With Bronchial Asthma
Condition: Asthma
Interventions: Drug: Fenoterol MDI; Drug: DSCG MDI
Sponsor: Boehringer Ingelheim
Terminated – verified June 2014
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
Evaluation of Tiotropium 2.5 and 5 Mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo and Salmeterol HydroFluoroAlkane (HFA) Metered Dose Inhaler (MDI) (50 Mcg Twice Daily) in Patient With Moderate Persistent Asthma II
Condition: Asthma
Interventions: Drug: 50 mcg salmeterol HFA MDI; Drug: placebo; Drug: 5 mcg tiotropium Respimat®; Drug: 2.5 mcg tiotropium Respimat®
Sponsors: Boehringer Ingelheim Pharmaceuticals; Pfizer
Recruiting – verified September 2010
View full post on ClinicalTrials.gov: “Asthma” | updated in the last 30 days